New! COVID-19 Guidance Document and ATS-CHEST Volunteer Matching Platform
There is little empirical evidence to guide management of COVID‐19. However, with 80,000
new cases being confirmed daily and the rate still increasing, clinicians taking care of patients with COVID‐19 need guidance now. Thus, ATS has released COVID‐19 Interim Guidance on Management Pending Empirical Evidence, from an American Thoracic Society‐led International Task Force.
CHEST and the ATS have also launched a volunteer-hospital matching platform, which seeks to match U.S.-trained, board certified critical care doctors with institutions in need of such expertise nationwide.
Volunteer today!
Boehringer Ingelheim Pharmaceuticals, Inc., Makes $500,000 Donation to Support COVID-19 Related ATS Activities
Yesterday, the American Thoracic Society announced that Boehringer Ingelheim Pharmaceuticals, Inc., donated $500,000 to support the ATS COVID-19 Crisis Fund, a newly launched initiative to develop and disseminate research, education, and scientific recommendations to providers in the pulmonary and critical care communities, as well as other clinicians in need of expanding their skill set during this emergency. Boehringer Ingelheim is the first to make a donation to the Fund. Read more!
Join Us Tomorrow for “The Tip of the Spear: The NYC/NJ COVID-19 Perspective”
Join the New York and New Jersey Thoracic Societies for a moderated panel discussion regarding treating COVID-19 in the U.S. epicenter.
When: 6:30 p.m. ET, April 9, 2020
Where: Online, register now.
Upcoming COVID-19 Webinars
ATS and ERS Joint Webinar - Global Perspectives on COVID-19: Italy, France, and Germany
The aim of this webinar series is to allow respiratory health professionals in different regions to share their experiences with COVID-19 so far and have an opportunity to ask their colleagues in other regions questions. This webinar will include practitioners and professors from Italy, France, and Germany.
All registrants will receive an archive link to view the completed webinar the following day. Please submit questions in advance.
When: 12 - 1 p.m. ET, April 13, 2020
Where: Online. Register now.
As part of "Sarcoidosis Week at the ATS" and in conjunction with PAR partner, the Foundation for Sarcoidosis Research, the American Thoracic Society will host a webinar, "Surviving with Sarcoidosis in the Era of Social Distancing," presented by Joseph Barney, MD, MSPH, of the University of Alabama at Birmingham.
When: 3 – 4 p.m. ET, April 15, 2020
Where: Online. Register now.
Bruno Ferreyro, MD Named 2020 Ziskind Clinical Research Scholar Awardee
Bruno Ferreyro, MD, has been named the 2020 Ziskind Clinical Research Scholar Awardee. Dr. Ferreyro is a fellow in the Oncologic Critical Care Program at the University Health Network/Sinai Health System, and a PhD candidate at the Institute of Health Policy, Management and Evaluation at the University of Toronto, Canada. Both his clinical and research interests relate to the care of critically ill immunocompromised patients.
The Ziskind Clinical Research Scholar Award is named in honor of Morton Ziskind, MD, a highly respected clinician and researcher from Tulane University who died in 1979. Dr. Ziskind, a long-time ATS member, was known for nurturing fellows and helping them become outstanding clinicians and clinical researchers.
